Question: is fasenra better than nucala?
Answer: Nucala reduced clinically significant exacerbations by 34% to 45% versus Fasenra across some subgroups and by 45% versus Cinqair in the eosinophil subgroup of >400 eosinophils. Asthma control was significantly improved with Nucala versus Fasenra and versus Cinqair in the high eosinophil count group.